XCELL THERAPEUTICS INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of 373110 for the last quarter is 457.81 M KRW, and it's 4.28% lower compared to the previous quarter. The net income of Q3 24 is -2.69 B KRW.